The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Transcriptional roles of nuclear factor κB and nuclear factor-interleukin-6 in the tumor necrosis factor α-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells.
Open accessAbstract
When a mouse osteoblastic cell line MC3T3-E1 was cultured in the presence of tumor necrosis factor alpha (TNF alpha), the release of prostaglandin E2 and the cyclooxygenase activity increased in a dose- and time-dependent manner. The increase of the enzyme activity was attributed mostly to the induction of cyclooxygenase-2 rather than cyclooxygenase-1 as judged by the inhibitory effect of NS398, Western blotting, and Northern blotting. In this system we attempted to elucidate the transcriptional regulation of the cyclooxygenase-2 gene. As examined by the luciferase assay, two positive regulatory regions (-186 to -131 and -512 to -385 base pairs) were found in the 5'-flanking promoter region of the mouse cyclooxygenase-2 gene in the TNF alpha-stimulated cells. The former included putative NF-IL6 (C/EBP beta) and AP2 elements, and the latter contained the NF kappa B motif. A DNA probe including the NF-IL6 and AP2 sites gave positive bands upon electrophoretic mobility shift assay using the nuclear extracts of MC3T3-E1 cells. The bands were supershifted by the addition of anti-NF-IL6 antibody but not by anti-AP2 antibody. A probe including the NF kappa B site also gave positive bands, which were supershifted by anti-NF kappa B p50 and p65 antibodies. Furthermore, when the motif of NF-IL6 or NF kappa B or both was subjected to point mutation, the luciferase activity was markedly reduced. These data suggested a potential role of both NF-IL6 and NF kappa B in the induction of cyclooxygenase-2 by TNF alpha.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One of the conundrums is that IL-6 is remarkably noninflammatory in tissues, and although there are some reports that IL-6 induces PGs in non-CNS cells, this seems to be uncommon and to occur at quite high concentrations (57) despite the presence of a nuclear factor IL-6 site upstream of the COX-2 gene (58).”
From Interleukin-6 is an afferent signal to the hypothalamo-pituitary-adrenal axis during local inflammation in mice (2003) · cites this paper as [58]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
Multiple nuclear factors interact with the immunoglobulin enhancer sequences
Sen, R., & Baltimore, D. (1986) · Cell · doi:10.1016/0092-8674(86)90346-6 · Cited by 2,754
Sudo, H., Kodama, H. A., Amagai, Y., Yamamoto, S., & Kasai, S. (1983) · The Journal of Cell Biology · doi:10.1083/jcb.96.1.191 · Cited by 1,673
NF-κB: A pleiotropic mediator of inducible and tissue-specific gene control
Lenardo, M. J., & Baltimore, D. (1989) · Cell · doi:10.1016/0092-8674(89)90833-7 · Cited by 1,542
A nuclear factor for IL‐6 expression (NF‐IL6) is a member of a C/EBP family.
Akira, S., Isshiki, H., Sugita, T., Tanabe, O., Kinoshita, S. M., Nishio, Y., Nakajima, T., Hirano, T., & Kishimoto, T. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08316.x · Cited by 1,450
The inducible transcription activator NF-κB: regulation by distinct protein subunits
Baeuerle, P. A. (1991) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(91)90007-8 · Cited by 1,025
Matsusaka, T., Fujikawa, K., Nishio, Y., Mukaida, N., Matsushima, K., Kishimoto, T., & Akira, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10193 · Cited by 959
Compilation of vertebrate-encoded transcription factors
Faisst, S., & Meyer, S. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.1.3 · Cited by 902
Futaki, N., Takahashi, S., Yokoyama, M., Arai, I., Higuchi, S., & Otomo, S. (1994) · Prostaglandins · doi:10.1016/0090-6980(94)90074-4 · Cited by 821
Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling
Wiegmann, K., Schütze, S., Machleidt, T., Witte, D., & Krönke, M. (1994) · Cell · doi:10.1016/0092-8674(94)90275-5 · Cited by 714
Research works printed but not linked: 4
- Xie, 1994, Mol. Cell. Biol., 14, 6531
- Kusaka, 1988, Biochim. Biophys. Acta, 972, 339
- Isshiki, 1990, Mol. Cell. Biol., 10, 2757
- Baeuerle, 1991, Biochim. Biophys. Acta, 1072, 63
Cited by
Sorted by citations
Items 201–300 of 645
Prostanoid Receptors of Murine NIH 3T3 and RAW 264.7 Cells
Arakawa, T., Laneuville, O., Miller, C. A., Lakkides, K. M., Wingerd, B. A., DeWitt, D. L., & Smith, W. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.47.29569 · Cited by 102
Mechanism of cyclooxygenase-2 upregulation in late preconditioning
Xuan, Y. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(03)00076-2 · Cited by 101
Barrios‐Rodiles, M., Tiraloche, G., & Chadee, K. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.2.963 · Cited by 101
Sonis, S. T., Odonnell, K., Popat, R., Bragdon, C., Phelan, S., Cocks, D., & Epstein, J. B. (2003) · Oral Oncology · doi:10.1016/s1368-8375(03)00148-9 · Cited by 100
Inhibition of Angiogenesis by Humulone, a Bitter Acid from Beer Hop
Shimamura, M., Hazato, T., Ashino, H., Yamamoto, Y., Iwasaki, E., Tobe, H., Yamamoto, K., & Yamamoto, S. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5934 · Cited by 98
Expressions of intestinal NF-κB, TNF-α, and IL-6 following traumatic brain injury in rats
Hang, C., Shi, J., Li, J., Li, W., & Wu, W. (2004) · Journal of Surgical Research · doi:10.1016/j.jss.2004.08.002 · Cited by 99
Guo, Y.-S., Cheng, J.-Z., Jin, G., Gutkind, J. S., Hellmich, M. R., & Townsend, C. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209016200 · Cited by 97
Matsuda, N., Hattori, Y., Jesmin, S., & Gando, S. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.005926 · Cited by 97
“The promoter regions of COX-2 and iNOS genes in murine cell lines contain at least one putative NF- B consensus sequence to act as positive regulatory element for their transcription (Xie et al., 1994; Yamamoto et al., 1995).”
BackgroundResveratrol, a natural chemopreventive agent against degenerative diseases.
Ignatowicz, E., & Baer‐Dubowska, W. (2001) · PubMed · Cited by 98
Angiotensin II induces TNF production by the thick ascending limb: functional implications
Ferreri, N. R., Escalante, B. A., Zhao, Y., An, S., & McGiff, J. C. (1998) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1998.274.1.f148 · Cited by 98
Kumagai, T., Kawamoto, Y., Nakamura, Y., Hatayama, I., Satoh, K., Osawa, T., & Uchida, K. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2967 · Cited by 98
IL-10 Is a Central Regulator of Cyclooxygenase-2 Expression and Prostaglandin Production
Berg, D., Zhang, J., Lauricella, D. M., & Moore, S. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2674 · Cited by 95
“Proinflammatory cytokines including TNF-a (13, 14), IL-1a (14, 15), and IFN-g (16, 17) have been demonstrated to induce COX-2 expression, whereas antiinflammatory cytokines such as IL-4 (18), IL-13 (19, 20), and IL-10 (21) can inhibit COX-2 induction.”
BackgroundInfluentialZhu, Y., Saunders, M. A., Yeh, H., Deng, W., & Wu, K. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108075200 · Cited by 94
Kolodkin‐Gal, D., Roitman, L., Ovadya, Y., Azazmeh, N., Assouline, B., Schlesinger, Y., Kalifa, R., Horwitz, S., Khalatnik, Y., Hochner-Ger, A., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-321112 · Cited by 93
Velagapudi, R., Aderogba, M. A., & Olajide, O. A. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.08.008 · Cited by 94
Obovatol attenuates LPS-induced memory impairments in mice via inhibition of NF-κB signaling pathway
Choi, D., Lee, J. W., GuiHua, L., Lee, Y. K., Lee, Y. H., Choi, I. S., Han, S., Jung, J., Kim, Y. H., Kim, K. H., et al. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.11.005 · Cited by 94
Function and Regulation of Prostaglandin Synthase 2
Herschman, H. R., Xie, W., & St, R. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4793-8_1 · Cited by 93
Gong, Y., Xue, B., Jiao, J., Jing, L., & Wang, X. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05653.x · Cited by 93
“A number of studies suggest that NF-jB activation and binding to the Cox-2 promoter region are required for inducing COX-2 expression (Yamamoto et al. 1995; Hwang et al. 1997).”
BackgroundHaseeb, A., Chen, D., & Haqqi, T. M. (2013) · Lara D. Veeken · doi:10.1093/rheumatology/kes363 · Cited by 92
Stadheim, T. A., Suh, N., Ganju, N., Sporn, M. B., & Eastman, A. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108974200 · Cited by 91
von Knethen, A., Callsen, D., & Brüne, B. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2858 · Cited by 92
Hewett, S. J., Bell, S. C., & Hewett, J. A. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.04.011 · Cited by 91
Kunnumakkara, A. B., Nair, S. A., Ahn, K. S., Pandey, M. K., Yi, Z., Liu, M., & Aggarwal, B. B. (2007) · Blood · doi:10.1182/blood-2007-01-067256 · Cited by 90
Joo, M., Hahn, Y. S., Kwon, M., Sadikot, R. T., Blackwell, T. S., & Christman, J. W. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7648-7657.2005 · Cited by 94
Oka, D., Nishimura, K., Shiba, M., Nakai, Y., Arai, Y., Nakayama, M., Takayama, H., Inoue, H., Okuyama, Ä., & Nonomura, N. (2007) · International Journal of Cancer · doi:10.1002/ijc.22570 · Cited by 89
Nuclear factor-κB activation promotes restitution of wounded intestinal epithelial monolayers
Egan, L. J., de Lecea, A., Lehrman, E. D., Myhre, G. M., Eckmann, L., & Kagnoff, M. F. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00167.2003 · Cited by 88
Woo, K. J., & Kwon, T. K. (2007) · International Immunopharmacology · doi:10.1016/j.intimp.2007.09.018 · Cited by 89
Barrios‐Rodiles, M., & Chadee, K. (1998) · PubMed · Cited by 89
Sung, B., Ahn, K. S., & Aggarwal, B. B. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4230 · Cited by 88
“TNF induces COX-2, which has NF-κB binding sites in its promoter (37).”
BackgroundIchikawa, H., Takada, Y., Murakami, A., & Aggarwal, B. B. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.7383 · Cited by 85
Newton, R. C., Cambridge, L., Hart, L. A., Stevens, D. A., Lindsay, M. A., & Barnes, P. J. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703431 · Cited by 85
“However, our results are consistent with the fact that the NF-kB, C/EBP and JNK signalling pathways, which do not involve p38 MAPK, are primarily thought to mediate COX-2 transcriptional induction (Inoue et al., 1995; Newton et al., 1997b; Xie & Herschman, 1995; Yamamoto et al., 1995).”
ResultNonsteroidal anti-inflammatory drugs suppress T-cell activation by inhibiting p38 MAPK induction
Paccani, S. R., Boncristiano, M., Ulivieri, C., D'Elios, M. M., Del Prete, G., & Baldari, C. T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110676200 · Cited by 84
Transcriptional Regulation of the Cyclooxygenase-2 Gene by Diverse Ligands in Murine Osteoblasts
Wadleigh, D. J., & Herschman, H. R. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1606 · Cited by 84
Srebrow, A., Friedmann, Y., Ravanpay, A. C., Daniel, C. W., & Bissell, M. J. (1998) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19980615)69:4 · Cited by 54
Cyclooxygenase‐2 and its regulation in inflammation
Bakhle, Y. S., & Botting, R. M. (1996) · Mediators of Inflammation · doi:10.1155/s0962935196000452 · Cited by 83
Yuan, S.-M., Gao, K., Wang, D., Quan, X., Liu, J., Ma, C., Qin, C., & Zhang, L. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.230 · Cited by 82
de Gregorio, R., Iñiguez, M. A., Fresno, M., & Alemany, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100885200 · Cited by 82
McGinty, A., Chang, Y. E., Sorokin, A., Bokemeyer, D., & Dunn, M. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.16.12095 · Cited by 81
Immunoreactivity of progesterone receptor isoform B, nuclear factor κB, and IκBα in adenomyosis
Nie, J., Lü, Y., Liu, X., & Guo, S. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.01.084 · Cited by 82
Sclabas, G. M., Uwagawa, T., Schmidt, C., Hess, K. R., Evans, D. B., Abbruzzese, J. L., & Chiao, P. J. (2005) · Cancer · doi:10.1002/cncr.21075 · Cited by 81
Ichikawa, H., Nair, M. S., Takada, Y., Sheeja, D. B. A., Kumar, M. A. S., Oommen, O. V., & Aggarwal, B. B. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0916 · Cited by 79
Cornwell, D. G., & Ma, J. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf8015877 · Cited by 79
Fernández‐Jiménez, N., Castellanos–Rubio, A., Plaza‐Izurieta, L., Irastorza, I., Elcoroaristizabal, X., Jauregi‐Miguel, A., López-Euba, T., Tutau, C., de Pancorbo, M. M., Vitoria, J. C., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt520 · Cited by 78
Links Among Growth Factors, Hormones, and Nuclear Factors With Essential Roles in Bone Formation
McCarthy, T. L., & Ji, C. (2000) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411000110040201 · Cited by 77
Molecular Mechanisms of Anticancer Activities of Puerarin
Ahmad, B., Khan, S., Liu, Y., Xue, M., Nabi, G., Kumar, S., Alshwmi, M., & Qarluq, A. W. (2020) · Cancer Management and Research · doi:10.2147/cmar.s233567 · Cited by 76
Buhrmann, C., Shayan, P., Banik, K., Kunnumakkara, A. B., Kubatka, P., Koklesová, L., & Shakibaei, M. (2020) · Biomedicines · doi:10.3390/biomedicines8080236 · Cited by 77
NF-κB in Cardiovascular Disease: Diverse and Specific Effects of a "General" Transcription Factor?
Jones, W. K., Brown, M. A., Wilhide, M. E., He, S., & Ren, X. (2005) · Cardiovascular Toxicology · doi:10.1385/ct:5:2:183 · Cited by 78
Effect of apocynin, a NADPH oxidase inhibitor, on acute lung inflammation
Impellizzeri, D., Esposito, E., Mazzon, E., Paterniti, I., Paola, R. D., Bramanti, P., & Cuzzocrea, S. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.12.006 · Cited by 78
Sol, V. V., & Fresno, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2825 · Cited by 77
“NF-B involvement in COX-2 induction by IFN-A NF-B site is the only regulatory element that has been identified so far in the 965/50 region from COX-2 promoter, and it participates in COX-2 induction by several proinflammatory stimuli like LPS or TNF in macrophages and other cell types (25, 26 ).”
BackgroundCOX-2–Dependent Cardiac Failure in Gh/tTG Transgenic Mice
Zhang, Z., Vezza, R., Plappert, T. A., McNamara, P., Lawson, J. A., Austin, S. C., Praticò, D., Sutton, M. S.-J., & FitzGerald, G. A. (2003) · Circulation Research · doi:10.1161/01.res.0000071749.22027.45 · Cited by 77
Seo, H., Park, K.-K., Han, S. S., Chung, W., Son, M., Kim, W. B., & Surh, Y. (2002) · International Journal of Cancer · doi:10.1002/ijc.10489 · Cited by 74
Inoh, H., Ishiguro, N., Sawazaki, S.-I., Amma, H., Miyazu, M., Iwata, H., Sokabe, M., & Naruse, K. (2002) · The FASEB Journal · doi:10.1096/fj.01-0354fje · Cited by 75
Bradbury, D. A., Newton, R. C., Zhu, Y. M., El-Haroun, H., Corbett, L. M., & Knox, A. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307964200 · Cited by 75
Li, B., Chen, M., Liu, X., & Guo, S. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.04.028 · Cited by 78
Calpain Inhibitor I Reduces the Development of Acute and Chronic Inflammation
Cuzzocrea, S., McDonald, M. C., Mazzon, E., Siriwardena, D., Serraino, I., Dugo, L., Britti, D., Mazzullo, G., Caputi, A. P., & Thiemermann, C. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64845-6 · Cited by 74
Overexpression of thioredoxin reductase 1 regulates NF‐κB activation
Sakurai, A., Yuasa, K., Shoji, Y., Himeno, S., Tsujimoto, M., Kunimoto, M., Imura, N., & Hara, S. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10377 · Cited by 73
“Both E-selectin and COX-2 genes are up-regulated by inflammatory stimuli through the activation of NF-kB (Yamamoto et al., 1995; Read et al., 1997).”
BackgroundRegulation of cyclooxygenase-2 expression by cyclic AMP
Klein, T., Shephard, P., Kleinert, H., & Kömhoff, M. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.09.001 · Cited by 73
Dirsch, V. M., Kiemer, A. K., Wagner, H., & Vollmar, A. M. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01245-4 · Cited by 73
Possible Involvement of Interleukin‐1 in Cyclooxygenase‐2Induction After Spinal Cord Injury in Rats
Tonai, T., Taketani, Y., Ueda, N., Nishisho, T., Ohmoto, Y., Sakata, Y., Muraguchi, M., Wada, K., & Yamamoto, S. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720302.x · Cited by 73
“Rabbit anti-murine COX-2 antibody prepared with a synthetic peptide corresponding to amino acids 579–594 of the murine enzyme (Yamamoto et al., 1995) was provided by Dr. Yoko Hayashi of Tokushima University School of Medicine.”
MethodFang, Z., Tang, Y., Ying, J., Tang, C., & Wang, Q. (2020) · Chinese Medicine · doi:10.1186/s13020-020-00359-1 · Cited by 75
A tale of two proteins: PACT and PKR and their roles in inflammation
Chukwurah, E., Farabaugh, K. T., Guan, B., Ramakrishnan, P., & Hatzoglou, M. (2021) · FEBS Journal · doi:10.1111/febs.15691 · Cited by 73
Dey, A., Wong, E. T., Cheok, C. F., Tergaonkar, V., & Lane, D. P. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402257 · Cited by 73
Sugimoto, T., Haneda, M., Sawano, H., Isshiki, K., Maeda, S., Koya, D., Inoki, K., Yasuda, H., Kashiwagi, A., & Kikkawa, R. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1271359 · Cited by 72
Kim, H., Lim, J. W., & Kim, K. H. (2001) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655201300191969 · Cited by 73
Kunnumakkara, A. B., Ichikawa, H., Anand, P., Mohankumar, C. J., Hema, P. S., Nair, M. S., & Aggarwal, B. B. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0432 · Cited by 73
RetractedCyclosporine A Suppresses Cyclooxygenase-2 Expression in the Rat Kidney
Höcherl, K., Dreher, F., Vitzthum, H., Diaeresis]hler, J. K., & Kurtz, A. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000031702.86799.b9 · Cited by 71
Khan, E., & Abu‐Amer, Y. (2003) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(03)00058-1 · Cited by 70
DAWN, B. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.03.012 · Cited by 69
“Similarly, the induction of COX-2, a comediator of late PC [7], is regulated by the activation of the jB-binding site in its promoter region [50].”
BackgroundTominari, T., Hirata, M., Matsumoto, C., Inada, M., & Miyaura, C. (2012) · Journal of Pharmacological Sciences · doi:10.1254/jphs.11188sc · Cited by 69
Kang, K., Kong, C., Seo, Y., Kim, M., & Kim, S. (2009) · Food and Chemical Toxicology · doi:10.1016/j.fct.2009.05.036 · Cited by 69
Han, J. W., Lee, B. G., Kim, Y. K., Yoon, J., Jin, H. K., Hong, S., Lee, H. Y., Lee, K. R., & Lee, H. W. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704099 · Cited by 69
“There are indications that activation of NF-kB is involved in iNOS and COX-2 expression because there is an NF-kB consensus site in the upstream promotor region of the iNOS and COX-2 gene (Yamamoto et al., 1995; Kim et al., 1997; Barnes & Karin, 1997; Cro ord et al., 1997).”
BackgroundCyclooxygenase 1 and cyclooxygenase 2 expression is abnormally regulated in human nasal polyps
Mullol, J., Fernández-Morata, J., Roca‐Ferrer, J., Pujols, L., Xaubet, A., Benitez, P. A., & Picado, C. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.123534 · Cited by 69
Posttranscriptional Regulation of Cyclooxygenase-2 in Rat Intestinal Epithelial Cells
Zhang, Z., Sheng, H., Shao, J., Beauchamp, R. D., & DuBois, R. N. (2000) · Neoplasia · doi:10.1038/sj.neo.7900117 · Cited by 69
Regulation of Cyclooxygenase-2 Expression by Nitric Oxide in Cells
Pérez‐Sala, D., & Lamas, S. (2001) · Antioxidants and Redox Signaling · doi:10.1089/152308601300185197 · Cited by 70
“The up-stream site is involved in IL-1 b - and TNF-a - elicited COX-2 induction (86, 137).”
Nakao, S., Ogata, Y., Shimizu-Sasaki, E., Yamazaki, M., Furuyama, S., & Sugiya, H. (2000) · Molecular and Cellular Biochemistry · doi:10.1023/a:1007155525020 · Cited by 69
Barrios‐Rodiles, M., & Chadee, K. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2441 · Cited by 69
Kim, C., Cho, S. K., Kim, K.-D., Nam, D., Chung, W., Jang, H.-J., Lee, S., Shim, B. S., Sethi, G., & Ahn, K. S. (2013) · APOPTOSIS · doi:10.1007/s10495-013-0957-9 · Cited by 73
Macrolide Therapy in Chronic Inflammatory Diseases
Kwiatkowska, B., & Maślińska, M. (2012) · Mediators of Inflammation · doi:10.1155/2012/636157 · Cited by 68
“Expression of genes involved in immune response and inflammation (e.g., iNOS, COX-2, TNF-alpha, IL-1, and IL-6) at the level of transcription is regulated by nuclear factor-kappa B (NF-κB) [13].”
BackgroundCiesielska, A., Joniec‐Maciejak, I., Przybyłkowski, A. M., Gromadzka, G., Iwona, Członkowska, A., & Członkowski, A. (2003) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2003-1461 · Cited by 68
Yamamoto, K., Wang, J., Yamamoto, S., & Tobe, H. (2000) · FEBS Letters · doi:10.1016/s0014-5793(99)01727-5 · Cited by 68
Hernández, M., Bayón, Y., Crespo, M. S., & Nieto, M. L. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731641.x · Cited by 68
“Moreover, TNF-a is a potent activator of the transcription factor NF-kB, and there are twokB-binding sites in the human COX-2 promoter, the functional relevance of which has been shown in different studies (Coyne et al., 1992; Jones et al., 1993; Yamamoto et al., 1995).”
BackgroundThe role of cyclooxygenase-2 (COX-2) in breast cancer, and implications of COX-2 inhibition
Singh‐Ranger, G., & Mokbel, K. (2002) · European Journal of Surgical Oncology · doi:10.1053/ejso.2002.1329 · Cited by 68
Ellrichmann, G., Thöne, J., Lee, D.-H., Rupec, R., Gold, R., & Linker, R. A. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-15 · Cited by 70
“via the inducible nitric oxide synthase (iNOS) [10] or cyclooxygenase-2 (COX-2) [11].”
BackgroundTrumble, T. N., Billinghurst, R. C., & McIlwraith, C. W. (2004) · American Journal of Veterinary Research · doi:10.2460/ajvr.2004.65.1269 · Cited by 67
Reuter, S., Prasad, S., Phromnoi, K., Ravindran, J., Sung, B., Yadav, V. R., Kannappan, R., Chaturvedi, M. M., & Aggarwal, B. B. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0037 · Cited by 67
Turnbull, A. V., Prehar, S., Kennedy, A. R., Little, R. A., & Hopkins, S. J. (2003) · Endocrinology · doi:10.1210/en.2002-220964 · Cited by 66
“One of the conundrums is that IL-6 is remarkably noninflammatory in tissues, and although there are some reports that IL-6 induces PGs in non-CNS cells, this seems to be uncommon and to occur at quite high concentrations (57) despite the presence of a nuclear factor IL-6 site upstream of the COX-2 gene (58).”
BackgroundSantarsiero, A., Convertini, P., Todisco, S., Pierri, C. L., Grassi, A., Williams, N. C., Iacobazzi, D., Stefano, G. D., O'Neill, L. A. J., & Infantino, V. (2021) · Cells · doi:10.3390/cells10112962 · Cited by 68
Futani, H., Okayama, A., Matsui, K., Kashiwamura, S., Sasaki, T., Hada, T., Nakanishi, K., 立石, 博., Maruo, S., & Okamura, H. (2002) · Journal of Immunotherapy · doi:10.1097/00002371-200203001-00009 · Cited by 66
“stimulation of PGE2 production through upregulation of cyclooxygenase (COX)-2 (5,14,15).”
BackgroundNovel synthetic coumarins that targets NF-κB in Hepatocellular carcinoma
Neelgundmath, M., Dinesh, K. R., Mohan, C. D., Li, F., Dai, X., Siveen, K. S., Paricharak, S., Mason, D. J., Fuchs, J. E., Sethi, G., et al. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.12.065 · Cited by 65
Multipotential and systemic effects of traumatic brain injury
Sabet, N., Soltani, Z., & Khaksari, M. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577619 · Cited by 70
Scheuren, N., Jacobs, M., Ertl, G., & Schorb, W. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1484 · Cited by 65
Nuclear factor κB is activated in small intestinal mucosa of celiac patients
Maiuri, M. C., Stefano, D. D., Mele, G., Fecarotta, S., Greco, L., Troncone, R., & Carnuccio, R. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0440-0 · Cited by 65
Murata, H., Tsuji, S., Tsujii, M., Sakaguchi, Y., Fu, H. Y., Kawano, S., & Hori, M. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700118 · Cited by 64
Ferrara, F., Woodby, B. L., Pecorelli, A., Schiavone, M. L., Pambianchi, E., Messano, N., Therrien, J., Choudhary, H., & Valacchi, G. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101481 · Cited by 64
D’Acquisto, F., Ialenti, A., Ianaro, A., Vaio, R. D., & Carnuccio, R. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301295 · Cited by 65
RetractedDual Effect of Nitric Oxide Donors on Cyclooxygenase-2 Expression in Human Mesangial Cells
Dı́az-Cazorla, M., Pérez‐Sala, D., & Lamas, S. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v105943 · Cited by 64
Cao, X., DONG, M., Shen, J., WU, B., Wu, C., Du, X., Wang, Z., QI, Y., & Лі, Б. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.12.010 · Cited by 63
Tamura, M., Sebastian, S., Yang, S., Gürateş, B., Ferrer, K., Sasano, H., Okamura, K., & Bulun, S. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201347200 · Cited by 63
Amma, H., Naruse, K., Ishiguro, N., & Sokabe, M. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706182 · Cited by 62
“…stimuli, hormones and mitogens, such as transforming growth factor b (TGF-b) (Sumitani et al., 1989; Jackson et al., 1993; Roy et al., 1996), interleukin-1 (IL-1) (Hla & Neilson, 1992; Jackson et al., 1993; Roy et al., 1996), and tumor necrosis factor a (TNF-a) (Yamamoto et al., 1995).”
BackgroundIL-33 facilitates proliferation of colorectal cancer dependent on COX2/PGE2
Li, Y., Shi, J., Qi, S., Zhang, J., Peng, D., Chen, Z., Wang, G., Wang, Z., & Wang, L. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0839-7 · Cited by 62
Metadata
- Authors
- Yamamoto, K., Arakawa, T., Ueda, N., & Yamamoto, S.
- Affiliations
- Tokushima University (JP)
- Corresponding author
- Yamamoto, Kei
- Yamamoto, Shozo
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1995-12
- Volume
- 270
- Issue
- 52
- Pages
- 31315-31320
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2002708977
- Cited by
- 647
- References
- 38
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 7 · 2023: 2 · 2022: 3 · 2021: 17 · 2020: 8 · 2019: 11 · 2018: 12 · 2017: 8 · 2016: 10 · 2015: 8 · 2014: 10 · 2013: 15 · 2012: 14
- FWCI
- 17.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Japan Foundation for Applied Enzymology
- Japan Research Foundation for Clinical Pharmacology
- Kissei
- Ono Pharmaceutical
- Japan Society for the Promotion of Science
- Daiichi Sankyo Company
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- cyclooxygenase-2, NF-κB, NF-IL6, C/EBPβ, TNF-α, transcriptional regulation, prostaglandin E2, MC3T3-E1 cells, osteoblasts, promoter regulation, gene induction
- MeSH terms
- Animals, Base Sequence, DNA-Binding Proteins, Enzyme Induction, Isoenzymes, Molecular Sequence Data, Nuclear Proteins, Oligodeoxyribonucleotides, Promoter Regions, Genetic, Prostaglandin-Endoperoxide Synthases, Regulatory Sequences, Nucleic Acid, Transcription, Genetic, Tumor Necrosis Factor-alpha, NF-kappa B, 3T3 Cells, CCAAT-Enhancer-Binding Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review